Showing results (61-70 of 10,339) with videos related to

Sort By:
Pageof 1,034
Annals of the Rheumatic Diseases|March 21, 2013
N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR)Hoda Mirjafari, Paul Welsh, Suzanne M M Verstappen, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosisThomas Wohlfahrt, Svetlana Usherenko, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled studyD A Isenberg, M Petri, K Kalunian, et al.
Annals of the Rheumatic Diseases|September 11, 2015
Tofacitinib regulates synovial inflammation in psoriatic arthritis, inhibiting STAT activation and induction of negative feedback inhibitorsW Gao, T McGarry, C Orr, et al.
Annals of the Rheumatic Diseases|December 25, 2015
Elevated calprotectin levels reveal bowel inflammation in spondyloarthritisH Cypers, G Varkas, S Beeckman, et al.
Annals of the Rheumatic Diseases|December 25, 2015
Proteinase-activated receptor 2 modulates OA-related pain, cartilage and bone pathologyCarmen Huesa, Ana C Ortiz, Lynette Dunning, et al.
Annals of the Rheumatic Diseases|January 30, 2016
Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)Erkan Demirkaya, Cengizhan Acikel, Philip Hashkes, et al.
Annals of the Rheumatic Diseases|January 16, 2016
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working groupRobert G W Lambert, Pauline A C Bakker, Désirée van der Heijde, et al.
Annals of the Rheumatic Diseases|July 1, 1989
Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritisM Dougados, L Duchesne, H Awada, et al.
Annals of the Rheumatic Diseases|January 7, 2016
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study)Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka, et al.
Pageof 1,034